Combating counterfeits is not a matter of developing software or systems or markings. Our research suggests that a multi-layered approach that adopts multiple strategies and engages the entire organization is needed. Initially, the size of the problem must be defined and the return on investment approximated. This can help define the need for a team of experts to work in this area, leading to a set of performance metrics that are aligned with business objectives and outcomes. Next, the key focal product seg ments should be targeted, and a system for identifying products through product trade mark registration with customs authorities should be completed.
We discuss the roles of Drug Serialization and the Drug Quality and Security Act, Pharmaceutical Security Institute Database, and technologies such as Blockchain for combating the counterfeiting problem.